Clinical Trials Sponsored by Amedica Corporation

Total 62764 results

Hamad Medical Corporation

Completed

Comparison Among Erythropoietin Stimulating Agents

Anemia of End Stage Renal Disease

Qatar
Atrium Medical Corporation

Completed

Large Diameter Advanta™ V12 Covered Stent Trial for Coarctation of the Aorta

Coarctation of the Aorta

Israel, Australia, Brazil, Canada, Germany, Italy, United Kingdom
Zoll Medical Corporation

Completed

Hospital Wearable Defibrillator Inpatient Study (HWD)

In-Hospital Cardiac Arrest

United States
SetPoint Medical Corporation

Completed

Safety and Efficacy Vagal Nerve Stimulation in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Netherlands, Bosnia and Herzegovina, Croatia
Atrium Medical Corporation

Completed

ClearWay™ RX Registry Trial

Heart Diseases | Vascular Diseases

United States
Hamad Medical Corporation

Unknown

Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient

RHEUMATOID ARTHRITIS

Qatar
Hamad Medical Corporation

Completed

Nebulized 5% Hypertonic Saline for the Treatment of Bronchiolitis

Bronchiolitis

Qatar
Zoll Medical Corporation

Recruiting

Central Sleep Apnea Prevalence and Impact on Cognitive Function in Patients With Heart Failure With Reduced or Mildly Reduced Left Ventricular Ejection Fraction (COG01)

Heart Failure | Central Sleep Apnea

Poland
Hamad Medical Corporation

Recruiting

High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients

Airway Extubation | Critical Care | Intensive Care | Oxygen Therapy

Qatar
Hamad Medical Corporation

Recruiting

To Compare the Effect of Receiving the Technology-based Training Along With the Conventional Therapy to the Conventional Therapy Alone on Executive Functions Among People With Traumatic Brain Injury With Mild to Moderate Cognitive Deficit

Traumatic Brain Injury

Qatar
Synaptic Medical Corporation

Recruiting

Treatment of PAF With the Synaptic System (Sensation)

Paroxysmal Atrial Fibrillation

United States
Hamad Medical Corporation

Recruiting

Comparison of Four Intensive Care Scores in Prediction of VA-ECMO Survival. (ECMO)

Cardiogenic Shock | Extracorporeal Membrane Oxygenation Complication

Qatar
Hamad Medical Corporation

Recruiting

Automated Inferior Vena Cava Collapsibility Index Fluid Responsiveness in Ventilated Patients After Cardiac Surgery.

Cardiac Surgery | Hemodynamic Monitoring | ICU

Qatar
Hamad Medical Corporation

Recruiting

Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia.

COVID-19 Pneumonia

Qatar
Hamad Medical Corporation

Recruiting

Effect of Human Plasma Protein Transfusion With and Without Crystalloids During Major Liver Resection Surgeries

Coagulation; Intravascular | Fluid Electrolyte Disorders

Qatar
Hamad Medical Corporation

Recruiting

Semi-rigid Ureteroscopy Versus Flexible Ureteroscopy For the Treatment of Proximal Ureteric Stone

Ureteric Stone | Stone Ureter

Qatar
Hamad Medical Corporation

Recruiting

Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis

Anaphylaxis

Qatar
Uro Medical Corporation

Recruiting

CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology (PROTECT)

Urinary Incontinence, Urge

United States
Hamad Medical Corporation

Recruiting

Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.

Bronchial Asthma

Qatar
Hamad Medical Corporation

Completed

Burn Injuries During COVID-19 Pandemic and Its Influence on Length of Stay

SARS-CoV-2 Infection

Qatar
Hamad Medical Corporation

Terminated

Maternal Telemental Health Interventions in Response to Covid-19* (CoronaVirus)

Specific Phobia | Perinatal Depression | Perinatal Anxiety

Qatar
Elixir Medical Corporation

Terminated

DESyne X2 Post Market Follow-up Study (DESyne X2 PMCF)

Coronary Artery Disease

China
Elixir Medical Corporation

Completed

Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial

Coronary Artery Disease

New Zealand, Belgium
Elixir Medical Corporation

Active, not recruiting

The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries (BIOADAPTOR RCT)

Coronary Artery Disease | Coronary Disease | Coronary Stenosis | Coronary Artery Stenosis

New Zealand, Belgium, Germany, Japan
Hamad Medical Corporation

Completed

Switch to Oral Antibiotics in Gram-negative Bacteremia (SOAB)

Escherichia Coli Bacteremia | Klebsiella Bacteraemia | Enterobacter Bacteraemia | Serratia Bacteraemia | Citrobacter Bacteraemia | Proteus Bacteraemia

Qatar, Turkey, Bahrain, Kuwait
Hamad Medical Corporation

Completed

Renal Involvement in Hospitalized Children With COVID-19 (RIHCC)

Coronavirus Infection | Covid19 | Renal Insufficiency | AKI | Acute Kidney Injury | Pediatric Kidney Disease | Renal Dysfunction

Qatar
Zoll Medical Corporation

Active, not recruiting

Benefits of µCor in Ambulatory Decompensated Heart Failure (BMADHF)

Heart Failure

United States, Germany, Austria
Terumo Medical Corporation

Completed

An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres (RAVI Registry)

Benign Prostatic Hyperplasia | Arteriovenous Malformations | Uterine Fibroid | Hypervascular Tumors

United States
Elixir Medical Corporation

Active, not recruiting

The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions

Coronary Artery Disease

New Zealand, Belgium, Netherlands, Czechia, Brazil
Elixir Medical Corporation

Completed

DynamX Bioadaptor Hong Kong Registry

Coronary Artery Disease

China
Hamad Medical Corporation

Completed

Arterial Line Patency in ICU Bound COVID-19 Patients

SARS-CoV-2 ICU Bound

Qatar
Zoll Medical Corporation

Enrolling by invitation

Pre-hospital Ventilation Clinical Study

Heart Failure | Sepsis | Hemorrhage | Cardiac Arrest | Respiratory Distress Syndrome, Adult | Altered Mental Status

United States
Hamad Medical Corporation

Completed

Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar (DOLCI)

Pneumonia | COVID | Coronavirus

Qatar
Hamad Medical Corporation

Completed

Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure

COVID-19 Patients | Hypoxemic Respiratory Failure | Prone Position

Qatar
Envoy Medical Corporation

Completed

Esteem New Subject Enrollment Post Approval Study

Sensorineural Hearing Loss

United States
Hamad Medical Corporation

Completed

An Evaluation Study to Identify the Effectiveness of Clinical Supervision With Regards to Work-related Strain, Sense of Coherence, Increased Cultural Sensitivity and the Impact on Patient's Care: A Prospective Longitudinal Study in Mental Health Services in Qatar

Work Related Stress | Sense of Coherence | Cultural Sensitivity | Clinical Supervision

Qatar
Zoll Medical Corporation

Completed

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients (MAPS)

Cardiac Arrhythmia

United States
Hamad Medical Corporation

Completed

Impact of Extra Corporal Membrane Oxygenation Services on Burnout Development in Intensive Care Units. (burnout)

Intensive Care Unit | Extracorporeal Membrane Oxygenation Complication | Burnout, Caregiver

Qatar
Terumo Medical Corporation

Completed

Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System

Vascular Closure

United States
Journey Medical Corporation

Completed

Study of Glycopyrronium in Axillary Hyperhydrosis

Hyperhidrosis

United States, Germany
Elixir Medical Corporation

Completed

Elixir Medical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - Cx Registry

Coronary Artery Disease

Belgium, Brazil
Zoll Medical Corporation

Completed

Feasibility Study of the µCor Heart Failure and Arrhythmia Management System (PATCH) (PATCH)

Heart Arrhythmia

Germany
Elixir Medical Corporation

Completed

DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System

Coronary Artery Disease

New Zealand
Hamad Medical Corporation

Completed

Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19

Covid19

Qatar
Zoll Medical Corporation

Terminated

Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study (WED-HED)

Sudden Cardiac Death | Sudden Cardiac Arrest

United States
Hamad Medical Corporation

Completed

Hyperbaric Oxygen Therapy Versus Core Decompression Augmented With Bone Substitute in Pre Collapse of Avascular Necrosis of Femoral Head

AVN

Qatar
Micron Medical Corporation

Withdrawn

Sacral Nerve Stimulation to Treat Urgency Urinary Incontinence With Wireless Neuromodulation

Urinary Incontinence, Urge

United States
Hamad Medical Corporation

Unknown

Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients (HCQ-COVID19)

COVID 19
Hamad Medical Corporation

Terminated

18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms

Polycythemia Vera | Essential Thrombocythemia | Primary Myelofibrosis, Prefibrotic Stage | Primary Myelofibrosis, Fibrotic Stage

Qatar
Hamad Medical Corporation

Unknown

Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf

Cardiovascular Diseases

Qatar

Clinical Trials Sponsored by Amedica Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations